Automated Reports and Custom Dashboards
Let DrugPatentWatch build custom dashboards and reports to take the load off of your team. We can ensure the production […]
Let DrugPatentWatch build custom dashboards and reports to take the load off of your team. We can ensure the production […]
This article was originally published by Hermann Mucke & Peter Mucke in Future Drug Discovery under a Attribution-NonCommercial-NoDerivatives 4.0 Unported
In a recent court ruling, the U.S. Court of Appeals for the Federal Circuit (CAFC) denied a petition to rehear
244 Drug Patents With Claims Containing “consisting essentially of” may be Unenforceable Read Post »
One of our clients, the Belarus Republican Scientific and Technical Library recently posted an article on how they support innovation.
Customer Success: DrugPatentWatch for Your Library Read Post »
Here’s a copy of the recent talk on Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition. It’s
DrugPatentWatch was used in a recent research study on branded drug sales following generic entry. In this paper, authors Jeffrey
DrugPatentWatch serves companies across the drug development-delivery sector. A common request among drug manufacturers, payers, and suppliers alike is anticipation
Customer Success: Will a generic version of a drug launch? And when? Read Post »
Changes in drug markets can create growth opportunities for API manufacturers and CDMOs alike. Whether change comes from generic entry,
Customer Success: API and CDMO Business Development Read Post »
DrugPatentWatch has deep resources to support patent prosecution and patent litigation, but it is also used by law firms for
Subscribe to our weekly newsletter below and never miss the latest product or an exclusive offer.